Stock Events

Stock Events

Paion 

$0.01
17
+$0+0% Tuesday 21:00

Statistics

Day High
0.05
Day Low
0.03
52W High
0.05
52W Low
0
Volume
16
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22AugExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q3 2020
Q1 2021
Q2 2021
-0.11
-0.07
-0.04
0
Expected EPS
0
Actual EPS
-0.1045

Financials

-2.1%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
70.71MRevenue
-1.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PAIOF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Paion in the development of drugs across various therapeutic areas, including anesthesia where Paion has a focus.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medications that can overlap with Paion's portfolio, including anesthesia and critical care.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is involved in the discovery, development, and marketing of drugs in areas that can compete with Paion's interests, particularly in anesthesia and pain management.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes with Paion in the pharmaceutical sector, focusing on areas including anesthesia and pain management, where Paion also operates.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is a global healthcare company that has a broad portfolio, including drugs in the anesthesia area, making it a competitor to Paion.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company is involved in the discovery and development of drugs in several therapeutic areas that could compete with Paion's focus areas.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates in various therapeutic segments, including areas that overlap with Paion's drug development efforts, making it a competitor.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global pharmaceutical company with a wide range of products that could compete with Paion, especially in the development of anesthesia-related treatments.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is involved in the creation and marketing of pharmaceutical products, including those in areas that compete with Paion's focus.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Ltd. is a global company that manufactures generic and specialty medicines, including those in the field of anesthesia, competing with Paion.

About

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for out-patient and hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in final stage of clinical development for use in procedural sedation, as well as in other indications, such as general anesthesia and intensive care unit sedation. It has partnerships and license agreements with Cosmo Pharmaceuticals, Yichang Humanwell, R-Pharm, TR-Pharm, Hana Pharm, Pharmascience, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.
Show more...
CEO
Mr. Gregor Siebert
Employees
64
Country
DE
ISIN
DE000A3E5EG5

Listings

LSE
GB
0NF3.LSE
OTC Link
US
PAIOF
F
DE
PA8.F

0 Comments

Share your thoughts

FAQ

What is Paion stock price today?▼
The current price of PAIOF is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Paion stock price performance more closely on the chart.
What is Paion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Paion stocks are traded under the ticker PAIOF.
Is Paion stock price growing?▼
PAIOF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Paion has showed a -50% decrease.
What were Paion earnings last quarter?▼
PAIOF earnings for the last quarter are -0.1 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Paion revenue for the last year?▼
Paion revenue for the last year amounts to 70.71M USD.
What is Paion net income for the last year?▼
PAIOF net income for the last year is -1.48M USD.
How many employees does Paion have?▼
As of March 15, 2026, the company has 64 employees.
In which sector is Paion located?▼
Paion operates in the Health Care sector.
When did Paion complete a stock split?▼
The last stock split for Paion was on April 12, 2023 with a ratio of 1:10.
Where is Paion headquartered?▼
Paion is headquartered in Aachen, DE.